Dermatology imaging devices market seen topping $3.97B by 2030

The Business Research Company says the dermatology imaging devices market will grow from $2.43 billion in 2025 to $2.71 billion in 2026, with longer-term forecasts pointing to $3.97 billion by 2030. The report ties demand to rising skin disease cases, teledermatology, and AI-enabled diagnostics.

Why it matters: - Dermatology imaging devices are becoming more important as clinics, hospitals, and telehealth providers need faster and more precise skin assessment tools. - The market’s projected growth signals more spending on early detection, digital diagnostics, and personalized treatment planning for skin disorders. - Rising melanoma and other skin disease cases are increasing demand for imaging systems that can support diagnosis and monitoring.

What happened: - The Business Research Company released a market outlook on dermatology imaging devices on Aug. 4, 2026. - The report says the market will grow from $2.43 billion in 2025 to $2.71 billion in 2026. - The report forecasts the market will reach $3.97 billion by 2030. - The report identifies North America as the largest market in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa as part of its regional analysis. - Download a free sample of the report. - View the full dermatology imaging devices market report.

The details: - Dermatology imaging devices capture high-resolution images of skin to help dermatologists examine abnormalities, track changes over time, make diagnoses, and guide treatment. - The report says the market’s recent growth has been driven by more skin cancer cases, higher awareness of dermatological conditions, growth in specialty dermatology clinics, wider use of digital diagnostic tools, and advances in optical imaging. - The report says future growth will be supported by AI-based diagnostic algorithms, early detection demand, teledermatology expansion, precision dermatology investment, and more personalized treatment planning. - The report links rising skin disorder prevalence to conditions including dermatitis, acne, eczema, psoriasis and skin cancer. - The report cites a City of Hope estimate that melanoma accounts for 5.5% of cancer diagnoses, or about 97,000 cases annually. - The same estimate says melanoma cases could rise to 7.1%, or about 151,000 a year, by 2030. - Teledermatology is expanding access to care in remote and underserved areas. - AI tools are speeding up skin image analysis and supporting earlier diagnosis.

Between the lines: - The market is shifting from standalone imaging hardware toward connected diagnostic workflows that combine remote care and algorithmic analysis. - North America’s lead suggests mature adoption and stronger clinical infrastructure, while Asia-Pacific’s growth points to faster capacity building and broader access. - The forecast implies the clearest commercial upside may come from systems that improve speed, accuracy and workflow efficiency rather than imaging alone.

What’s next: - The Business Research Company says 2026 editions of its reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, and updated graphics and tables. - More investment is likely to flow toward AI-enabled imaging, teledermatology-ready platforms and tools aimed at earlier skin disease detection.

The bottom line: - Dermatology imaging devices are moving from niche diagnostic tools to a larger, faster-growing part of digital skin care, with the strongest demand tied to AI, telehealth and earlier diagnosis.